Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intralipid for Pregnancy Complications in Antiphospholipid Syndrome
NCT04274803Phase 4Withdrawn
- Sponsor
- Tanta University
- Start
- Apr 2020
- Primary completion
- May 2021
- Modality
- Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Intralipid 10% in antiphospholipid syndrome (APS), sponsored by Tanta University. Planned start Apr 2020; status: withdrawn.
02
Drugs
Intralipid 10%
03
Conditions
antiphospholipid syndrome (APS)
Beyond the preview
Go deeper on NCT04274803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04274803.